Ein Business-Meeting (Symbolbild).
Montag, 30.06.2014 19:30 von | Aufrufe: 267

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Auxilium Pharmaceuticals Inc. and Its Board of Directors In Connection With the Sale of the Company to QLT Inc. -- AUXL

Ein Business-Meeting (Symbolbild). © gilaxia / E+ / Getty Images

PR Newswire

NEW YORK, June 30, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or "the Company") (NasdaqGS: AUXL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to QLT Inc. (NasdaqGS: QLTI).

Protecting the Rights of Shareholders

Click here to learn more about the investigation: http://zlk.9nl.com/auxilium-pharmaceuticals-auxl, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Auxilium shareholders will receive 3.1359 shares of QLT Inc. for each share of Auxilium they own. The investigation concerns whether the Board of Auxilium breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether QLT Inc. is underpaying for Auxilium shares.

If you own Auxilium common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/auxilium-pharmaceuticals-auxl.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com


ARIVA.DE Börsen-Geflüster

SOURCE Levi & Korsinsky, LLP

Werbung

Mehr Nachrichten zur Novelion Therapeutics Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.